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Introduction
MRI is an excellent diagnostic tool for serial assessment of
changes in myocardial perfusion, left ventricular function,
and infarct size. In chronic total occlusions (CTO) the
effects of recanalization on perfusion and function are
contradictory and might depend primarily on viability.
Circulating progenitor cells (CPC) injected intracoronar-
ily after successful CTO recanalization might improve per-
fusion and function.
Purpose
To assess, if CPC improve perfusion and subsequently inf-
arct size and left ventricular function in comparison to
control.
Methods and results
Twenty-eight patients with reperfused CTO were rand-
omized to either CPC's or inactive serum (control), which
were infused into the target vessel. First-pass myocardial
perfusion MRI at rest and stress using adenosine at stand-
ard dose revealed a significant improvement of the myo-
cardial perfusion reserve index (MPRI) in the affected
segments. The baseline MPRI in affected segments was
1.50 ± 0.17 in CPC versus 1.46 ± 0.16 in control (p =
0.62). In CPC the MPRI improved to 1.76 ± 0.16 (p <
0.001) at 3 and 1.82 ± 0.20 (p < 0.001) at 15 months; in
control the change was 1.58 ± 0.10 (p = 0.01) at 3 and
1.61 ± 0.08 (p = 0.004) at 15 months follow-up. However,
the MPRI recovery was significantly better in CPC as com-
pared to control at 3 (p = 0.004) and 15 months (p =
0.005). In remote myocardium the MPRI was 1.70 ± 0.30
and 1.69 ± 0.25 (p < 0.01 versus affected segments),
respectively. At follow-up there was no significant
improvement for both groups. The change in MPRI at 3
and 15 months was correlated with a change in overall
infarct size for CPC (3 months: r = -0.68, p = 0.02; 15
months: r = -0.81, p = 0.001), whereas in control there was
no correlation (r = -0.38, p = 0.26; 15 months: r = -0.21, p
= 0.56). Infarct transmurality influenced MPRI improve-
ment at follow-up. CPC patients had a trend towards
more improved segments in particular those with higher
transmurality (Figure 1).
Conclusion
Analysis of serial contrast-enhanced MRI suggests that
intracoronary application of CPC post recanalization of
CTO is associated with improved myocardial perfusion
and subsequent improved recovery of left ventricular
function as compared to a control group at mid- and long-
term follow-up. Further investigations of the pathophysi-
ological CPC effects on macro- and microvascular func-
tion are required.
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Endothelial progenitor cells in addition to recanalization of chronic total occlusions improve myocardial perfusion and subse-quen ly infarct size and l ft ventricular ejection fractionFigure 1
Endothelial progenitor cells in addition to recanalization of chronic total occlusions improve myocardial perfusion and subse-
quently infarct size and left ventricular ejection fraction.Page 2 of 2
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